Portal:Lipids/PathwayList
From WikiPathways
(Difference between revisions)
| Line 6: | Line 6: | ||
==== Extend existing pathways with new literature ==== | ==== Extend existing pathways with new literature ==== | ||
| - | * [https://doi.org/10.1002/cm.21067 More proteins], [https://doi.org/10.1002/bies.201300064 localisation], details on [https://doi.org/10.1111/febs.12116 | + | * [https://doi.org/10.1002/cm.21067 More proteins], [https://doi.org/10.1002/bies.201300064 localisation], details on regulation of (endocytic) membrane traffic [https://doi.org/10.1111/febs.12116] and [https://doi.org/10.1242/jcs.02855] by phosphoinositide 3-kinases, and [https://doi.org/10.1016/j.febslet.2012.04.046 activity and tumor suppression] thereof for [https://www.wikipathways.org/index.php/Pathway:WP4971 WP4971]. |
==== Start a new pathway! ==== | ==== Start a new pathway! ==== | ||
Revision as of 13:33, 1 October 2020
Contents |
Create new pathways
- Public resources for pathway information: LIPID MAPS and SwissLipids.
- See our Help section for New Contributor QuickStart, Editor's Palette Guide and Guidelines for Contributors.
Extend existing pathways with new literature
- More proteins, localisation, details on regulation of (endocytic) membrane traffic [1] and [2] by phosphoinositide 3-kinases, and activity and tumor suppression thereof for WP4971.
Start a new pathway!
- Phosphoinositide Signaling
- PI3-K in Human diseases
- Class I PI3-K Isoforms in Endometrial Cancer
- Inositol trisphosphate receptor
Improve existing pathways
| Sphingolipid Metabolism (integrated pathway) (mouse) |
| Elongation of (very) long chain fatty acids (mouse) |
Contact us
Send questions about WikiPathways to the wikipathways-discuss mailing list.
How to add a pathway to the portal
The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact the administrator.
